The University of Texas at Arlington, Arlington, TX, USA.
Barbra Streisand Women's Heart Center, Cedars-Sinai Smidt Heart Institute, Los Angeles, CA, USA.
Int J Cardiol. 2021 May 15;331:1-7. doi: 10.1016/j.ijcard.2021.01.064. Epub 2021 Feb 2.
Ischemia with no obstructive coronary artery disease (INOCA) is prevalent in women and is associated with increased risk of developing heart failure with preserved ejection fraction (HFpEF); however, the mechanism(s) contributing to this progression remains unclear. Given that diastolic dysfunction is common in women with INOCA, defining mechanisms related to diastolic dysfunction in INOCA could identify therapeutic targets to prevent HFpEF.
Cardiac MRI was performed in 65 women with INOCA and 12 reference controls. Diastolic function was defined by left ventricular early diastolic circumferential strain rate (eCSRd). Contributors to diastolic dysfunction were chosen a priori as coronary vascular dysfunction (myocardial perfusion reserve index [MPRI]), diffuse myocardial fibrosis (extracellular volume [ECV]), and aortic stiffness (aortic pulse wave velocity [aPWV]).
Compared to controls, eCSRd was lower in INOCA (1.61 ± 0.33/s vs. 1.36 ± 0.31/s, P = 0.016); however, this difference was not exaggerated when the INOCA group was sub-divided by low and high MPRI (P > 0.05) nor was ECV elevated in INOCA (29.0 ± 1.9% vs. 28.0 ± 3.2%, control vs. INOCA; P = 0.38). However, aPWV was higher in INOCA vs. controls (8.1 ± 3.2 m/s vs. 6.1 ± 1.5 m/s; P = 0.045), and was associated with eCSRd (r = -0.50, P < 0.001). By multivariable linear regression analysis, aPWV was an independent predictor of decreased eCSRd (standardized β = -0.39, P = 0.003), as was having an elevated left ventricular mass index (standardized β = -0.25, P = 0.024) and lower ECV (standardized β = 0.30, P = 0.003).
These data provide mechanistic insight into diastolic dysfunction in women with INOCA, identifying aortic stiffness and ventricular remodeling as putative therapeutic targets.
无阻塞性冠状动脉疾病(INOCA)伴缺血在女性中较为普遍,且与射血分数保留的心力衰竭(HFpEF)风险增加相关;然而,导致这种进展的确切机制尚不清楚。鉴于INOCA 女性中存在舒张功能障碍,确定与 INOCA 舒张功能障碍相关的机制可以确定预防 HFpEF 的治疗靶点。
对 65 名 INOCA 女性和 12 名参考对照者进行心脏 MRI 检查。通过左心室早期舒张环向应变率(eCSRd)定义舒张功能。预先选择冠状动脉血管功能障碍(心肌灌注储备指数 [MPRI])、弥漫性心肌纤维化(细胞外容积 [ECV])和主动脉僵硬度(主动脉脉搏波速度 [aPWV])作为舒张功能障碍的原因。
与对照组相比,INOCA 患者的 eCSRd 降低(1.61 ± 0.33/s 比 1.36 ± 0.31/s,P = 0.016);然而,当 INOCA 组根据低和高 MPRI 进一步细分时,这种差异并不明显(P > 0.05),并且 INOCA 患者的 ECV 并未升高(29.0 ± 1.9% 比 28.0 ± 3.2%,对照组比 INOCA;P = 0.38)。然而,与对照组相比,INOCA 患者的 aPWV 更高(8.1 ± 3.2 m/s 比 6.1 ± 1.5 m/s;P = 0.045),且与 eCSRd 相关(r = -0.50,P < 0.001)。通过多变量线性回归分析,aPWV 是 eCSRd 降低的独立预测因子(标准化β=-0.39,P = 0.003),左心室质量指数升高(标准化β=-0.25,P = 0.024)和 ECV 降低(标准化β=0.30,P = 0.003)也是如此。
这些数据为 INOCA 女性舒张功能障碍的机制提供了深入了解,确定了主动脉僵硬度和心室重构作为潜在的治疗靶点。